cardiovascular system
• atherosclerotic lesions are reduced 52% at 35 weeks, 32% at 53 weeks, and 36% at 60 weeks compared to in Apoetm1Unc homozygotes
|
homeostasis/metabolism
• total and non-HDL cholesterol after 60 weeks compared to in Apoetm1Unc homozygotes
|